Trexquant Investment LP Clearside Biomedical, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $119,048 - $250,352	-43,768 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $211,399 - $315,129	43,768 New	43,768 $263,000
Q4 2018 Feb 13, 2019	SELL	$1.0 - $6.12 $30,539 - $186,898	-30,539 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$6.03 - $11.24 $184,150 - $343,258	30,539 New	30,539 $188,000
Q1 2018 May 03, 2018	SELL	$5.57 - $14.28 $199,756 - $512,123	-35,863 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$5.78 - $9.12 $207,288 - $327,070	35,863	35,863 $251,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.